Bemiparin in neonatal thrombosis: therapeutic dosing and safety
- 16 December 2024
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (2) , 224-228
Abstract
Objective To evaluate the therapeutic dose and safety of bemiparin in neonatal thrombosis treatment. Study design A retrospective review was conducted on infants treated with bemiparin between 2018 and 2023 at a tertiary hospital. Results 72 neonates with a mean gestational age of 37 weeks were included. Twenty were preterm, with a median gestational age of 33.5 weeks and a median birth weight of 1847.5 grams. The mean (SD) initial and therapeutic bemiparin doses were 170.5 (31) and 200 (37.2) IU/kg/day, respectively. Only 32% of patients reached the therapeutic target range (TTR) with the initial dose. Preterm infants required higher doses to reach TTR (215 vs 194.7 IU/kg/day, p = 0.05). Adverse events were minimal (1.4%) and unrelated to the starting dose or prematurity. Conclusion Bemiparin appears to be a potential therapeutic option for anticoagulation in neonates; however, targeted anti-Xa levels were rarely achieved with the initial dose and most patients required uptitration.Keywords
This publication has 43 references indexed in Scilit:
- Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and HemostasisJournal of Thrombosis and Haemostasis, 2023
- Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit—A Case Control StudyThe Journal of Pediatrics, 2018
- Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled TrialClinical Drug Investigation, 2017
- Anticoagulation therapy in neonates, children and adolescentsBlood Cells, Molecules, and Diseases, 2017
- Heparin for the treatment of thrombosis in neonatesCochrane Database of Systematic Reviews, 2016
- Thromboembolism and anticoagulation management in the preterm infantSeminars in Fetal and Neonatal Medicine, 2016
- Thrombosis in the Neonatal Intensive Care UnitClinics in Perinatology, 2015
- Bemiparin, an effective and safe low molecular weight heparin: A reviewVascular Pharmacology, 2014
- Enoxaparin for neonatal thrombosis: A call for a higher dose for neonatesThrombosis Research, 2008
- Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic ComplicationsThe Journal of Pediatrics, 1998